The U.K. government is asking GlaxoSmithKline for more information on its China bribery scandal, AstraZeneca made two deals during U.K. Prime Minister Theresa May's state visit to China, Samsung BioLogics' plant expansions helped grow sales by 56% in 2017, and more.Original Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.